GYKI-46903

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameGYKI-46903
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M3 antagonistsSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 3 (5-HT3) receptorMuscarinic acetylcholine receptor M3
Therapy Area/IndicationsCognition DisordersVomitingNausea
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIvax Drug Research Institute Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIvax Drug Research Institute Ltd
Active IndicationsN/A
Inactive IndicationsCognition DisordersVomitingNausea

Other Information

ATC CodeN/A
Related LinksN/A